A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emph...
Enregistré dans:
| Auteurs principaux: | Mark Klein MD, Vinh Dao PharmD, BCPS, Fatima Khan MD, MPH |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
SAGE Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
par: Shahrzad Salmasi, Msc, et autres
Publié: (2021) -
Postoperative Nosocomial COVID-19 Infection in Cardiac Surgery: An Uncommon Event With High Mortality Rate
par: Khalid Ridwan, MD, MSc, et autres
Publié: (2021) -
The Heart-Team Approach for the Treatment of Radiation-Induced Aortic Stenosis and Coronary Artery Disease: A Case ReportNovel Teaching Points
par: Eve Belzile-Dugas, MD, et autres
Publié: (2021) -
The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
par: Islam Eljilany MSc, et autres
Publié: (2021) -
Myocardial fibrosis and its correlation with the predictors of morbidity and mortality in Eisenmenger syndrome
par: K. Divyashree, et autres
Publié: (2021)